###### Key messages

What is already known about this subject?
=========================================

-   Some previous studies suggested an association between parental occupational exposure to extremely low-frequency magnetic fields (ELF-MF) and leukaemia in their offspring; however, the evidence is inconsistent.

What are the new findings?
==========================

-   We evaluated this research question in the largest case--control study consortium on childhood leukaemia and did not find association with parental occupational ELF-MF exposure.

How might this impact on policy or clinical practice in the foreseeable future?
===============================================================================

-   These findings increase our understanding of childhood leukaemia aetiology.

Background {#s1}
==========

Leukaemia is the most common cancer in children diagnosed before 15 years of age worldwide, with acute lymphoblastic leukaemia (ALL) as most common (\~75%) and acute myeloid leukaemia (AML) as second most common subtype (\~15%).[@R1]

In addition to some well-established risk factors of childhood leukaemia (ie, a few hereditary conditions, exposure to high-dose ionising radiation and prior chemotherapy), many studies worldwide have suggested several possible factors associated with increased (or decreased) risk of the disease such as birth characteristics, immune-related markers and environmental pollutants.[@R3]

Early age at diagnosis indicates that childhood cancer might originate in utero and that exposures prior to birth including parental occupational exposures and early-life environmental exposures may be important determinants.[@R8]

Plausible underlying mechanisms for associations between parental exposures and childhood leukaemia are dependent on the time of exposure and which parent is exposed. Preconception exposures of parents are assumed to affect parental germ cells, while maternal exposures during pregnancy may affect the fetal development.[@R10]

Associations between residential extremely low-frequency magnetic field (ELF-MF) exposures and childhood leukaemia were observed in a pooled analysis of studies conducted before 2000[@R11] and confirmed in a pooled analysis of more recent studies.[@R13] Risk assessments by the International Agency for Research on Cancer,[@R14] the WHO[@R15] and the European Commission's Scientific Committee on Emerging and Newly Identified Health Risks came to similar conclusions[@R16] that ELF-MF are possibly carcinogenic.

Some studies also reported associations with parental occupational ELF-MF exposure.[@R17] However, these findings were not consistent with findings from other studies.[@R21] Hug *et al* [@R22] included a meta-analysis in their report finding a summary relative risk estimate of 1.35 (95% CI 0.95 to 1.91) for paternal occupational exposure and also some evidence of publication bias, endorsing the need of further studies.

The Childhood Leukemia International Consortium (CLIC) is composed of case--control studies providing an opportunity to study even rare risk factors in relation to childhood leukaemia.[@R24] Building on the wealth of data and biospecimens collected in over 20 case--control studies worldwide, CLIC was established in 2007, to overcome the limitations of single epidemiological studies.[@R24]

In this study, we aimed to assess the association of parental occupational exposure to ELF-MF with the risk of leukaemia in their offspring. We hypothesise that paternal occupational ELF-MF exposures occurring around conception and maternal ELF-MF exposures during pregnancy may be associated with leukaemia risk in the offspring.

Methods {#s2}
=======

Study population {#s2a}
----------------

A total of 11 case--control studies from eight countries in Europe, the USA and New Zealand contributed to the pooled analysis of ALL, and 10 studies contributed to the analyses of AML ([table 1](#T1){ref-type="table"}).

###### 

Characteristics of studies included in the CLIC pooled analysis of parental exposure to occupational low-frequency magnetic fields (EMF-MF) and risk of childhood leukaemia

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Country, study (years of case accrual)   Cases                                                     Controls      Source of occupational history data                                            Time period(s) of interest\*   Original occupational coding                                            Occupational conversion tool to ISCO-88                                                                                                                                                                                                                                                                                                       
  ---------------------------------------- --------------------------------------------------------- ------------- ------------------------------------------------------------------------------ ------------------------------ ----------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------
  Finland\                                 Finnish Cancer Registry                                   ALL: 857.\    Population register centre.                                                    3277                           Population census records (1990, 1995, 2000, 2005 and 2010).            Extracted from census records: (1) Census record preceding conception and (2) Census record preceding pregnancy.                                                                                                                                           ISCO 1988 and\                                                                     Correspondence table ISCO-08 to ISCO-88.
  (1990--2011)                                                                                       AML: 127.                                                                                                                                                                                                                                                                                                                                                                                                                                                      ISCO 2008.                                                                         

  France, ADELE\                           Hospitals                                                 ALL: 240.\    Hospitals (same as cases).                                                     288                            Self-administered questionnaire, telephone or face-to-face interview.   Extracted from work history (start and end year of each job): (1) main year before conception (defined as the year of the midpoint of the year before conception) and (2) main year of pregnancy (defined as the year of the midpoint of the pregnancy).   ISCO 1988.                                                                         
  (1993--1999)                                                                                       AML: 35.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  France, ESCALE\                          Population-based cancer registry (nationwide).            ALL: 641.\    Population quotas by age, sex and region (nationwide).                         1681                           Self-administered questionnaire, telephone or face-to-face interview.   1\. During pregnancy†.                                                                                                                                                                                                                                     ISCO 1968.                                                                         Correspondence table ISCO-68 to ISCO-88.
  (2003--2004)                                                                                       AML: 97.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Germany, GCCR\                           Childhood cancer registry (nationwide).                   ALL: 741.\    German registries of residents (regional registries with national coverage).   2457                           Self-administered questionnaire, telephone or face-to-face interview.   \(1\) At conception and (2) during pregnancy.                                                                                                                                                                                                              German, Bundesagentur für Arbeit.                                                  Correspondence table to ISCO-88 obtained from Federal Statistical Office, Germany.
  (1992--1994)                                                                                       AML: 122.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Greece, NARECHEM\                        Nationwide hospital cancer registry.                      ALL: 140.\    Hospital.                                                                      300                            Self-administered questionnaire, telephone or face-to-face interview.   \(1\) One year before birth and (2) during pregnancy.                                                                                                                                                                                                      ISCO 1988.                                                                         
  (1993--1994)                                                                                       AML: 13.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Greece, NARECHEM\                        Nationwide hospital cancer registry.                      ALL: 957.\    Hospital.                                                                      1085                           Self-administered questionnaire, telephone or face-to-face interview.   \(1\) One year before birth and (2) during pregnancy.                                                                                                                                                                                                      ISCO 1968.                                                                         Correspondence table ISCO-68 to ISCO-88.
  (1996--2011)                                                                                       AML: 112.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Italy, SETIL\                            Clinical cancer registry (nationwide).                    ALL: 596.\    Registry (nationwide).                                                         1044                           Self-administered questionnaire, telephone or face-to-face interview.   \(1\) One year before conception and (2) during pregnancy.                                                                                                                                                                                                 ISCO 1968.                                                                         Correspondence table ISCO-68 to ISCO-88.
  (1998--2001)                                                                                       AML: 32.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  New Zealand, NZCCS\                      Registries (nationwide) and admission/discharge system.   ALL: 97.\     Birth registry (nationwide).                                                   303                            Self-administered questionnaire, telephone or face-to-face interview.   \(1\) Two years before birth and (2) during pregnancy.                                                                                                                                                                                                     UK, Standard Occupational Classification 1990.                                     Correspondence table to ISCO-88 obtained from Office for National Statistics, UK.
  (1990--1993)                                                                                       AML: 22.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  UK, UKCCS\                               Nationwide general practitioners' registry.               ALL: 1427.\   GP registries (nationwide).                                                    3447                           Self-administered questionnaire, telephone or face-to-face interview.   \(1\) Around conception and (2) during pregnancy.                                                                                                                                                                                                          UK, Standard Occupational Classification 1990.                                     Correspondence table to ISCO-88 obtained from Office for National Statistics, UK.
  (1991--1996)                                                                                       AML: 234.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  USA, COG-E15\                            Children's Cancer Group clinical trials.                  ALL: 1910.    RDD                                                                            1986                           Self-administered questionnaire, telephone or face-to-face interview.   Extracted from work history (start and end month, year of each job): (1) year before conception and (2) during pregnancy.                                                                                                                                  US, Department of Labour Dictionary of Occupational Titles (4th ed., rev. 1991).   Correspondence tables obtained from the National Crosswalk Center between DOT to 2000 Census codes, and 2000 Census codes to ISCO-88.
  (1989--1993)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  USA, CCLS\                               Hospitals.                                                ALL : 814.\   Birth registry (state wide).                                                   1224                           Self-administered questionnaire, telephone or face-to-face interview.   Extracted from work history (start and end month, year of each job): (1) year before conception and (2) during pregnancy.                                                                                                                                  US, Census Occupational Classification Codes 1990.                                 Correspondence tables obtained from the National Crosswalk Center between 1990 Census to 2000 Census codes, and 2000 Census codes to ISCO-88.
  (1995--2008)                                                                                       AML : 132.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Time periods of interest were: (1) around conception for the father and (2) during pregnancy for the mother.

†In France ESCALE, paternal exposure during pregnancy was used as a proxy for exposure at conception as these data were not available.

ADELE, Adele Study; ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia; CCLS, California Childhood Leukemia Study; CLIC, Childhood Leukaemia  International Consortium; COG, Children's Oncology Group; DOT, Dictonary of Occupational Titles; ESCALE, Epidemiologic Study on Childhood Cancer and Leukemia; GCCR, German Childhood Cancer Registry; GP, General Population; ISCO, International Standard Classification of Occupations; NARECHEM, Nationwide Registry for Childhood Haematological Malignancies; NZCCS, New Zealand Childhood Cancer Study; RDD, random digit dialling; SETIL, Studio sulla Eziologia dei Tumori Infantili Linfoemopoietici; UKCCS, United Kingdom Childhood Cancer Study.

In total, our study population included 9723 childhood leukaemia cases and 17 099 controls. Overall leukaemia cases consisted of ALL (B-lineage, T-lineage and other), AML and other types of leukaemia. We excluded 171 (1.8%) cases and 6 (\<0.01%) controls with Down syndrome, a condition known to be a risk factor for the development of childhood leukaemia.

Cases were diagnosed between 1989 and 2011 and were identified from national or regional population-based cancer registries, networks of hospitals, selected hospitals or clinical trials.[@R24] Control subjects were recruited from population registries, same hospitals as cases or by using random digit dialling. Cases and controls were less than 15 years of age at date of diagnosis (or equivalent date for controls) ([table 1](#T1){ref-type="table"}).

Data collection {#s2b}
---------------

Information on parental occupation and characteristics of the children was collected using standardised questionnaires, with in-person or telephone interviews of both parents in 10 of the contributing studies. In the register-based study from Finland, occupational data were obtained from census records in 1990, 1995, 2000, 2005 and 2010, and other characteristics from various nationwide population-based registries. Details of data collection in Finland are reported elsewhere.[@R25]

Characteristics of interest included the child's sex, age, birth weight, birth order, ethnicity, as well as parental age at child's birth, parental education and occupation. We categorised continuous covariates or recoded categorical ones according to standard categorizations previously used across CLIC studies.[@R6]

Parental occupations were coded using the International Standard Classification of Occupations (ISCO) from 1968, 1988 and 2008 in Finland, 1968 and 1988 in France and Greece and 1968 in Italy. In other countries, national job classifications were used ([table 1](#T1){ref-type="table"}); see below how those data were harmonised for the present pooling effort.

Exposure assessment {#s2c}
-------------------

We defined time periods of interest as at conception for the father and during pregnancy for the mother. Parental occupational ELF-MF exposure was estimated by linking job titles to an existing quantitative ELF-MF job-exposure matrix (ELF-MF JEM). We used an ELF-MF JEM developed for the INTEROCC study,[@R27] which is a multinational case--control study of adult brain tumours and occupational risk factors. The INTEROCC JEM originally developed by Bowman *et al* [@R28] was substantially enhanced by adding measurement data on jobs included in the INTEROCC study based on summary statistics or primary data from published occupational ELF-MF measurement studies in Canada, England, Finland, Italy, the Netherlands, New Zealand, Sweden and the USA.[@R27] Further details of the ELF-MF JEM can be found elsewhere.[@R27]

The INTEROCC JEM was considered applicable to the CLIC dataset for three reasons. First, this JEM is based on data from countries that greatly overlap with the countries from which the CLIC data originates. Second, ELF-MF measurements used for its construction stem from time periods sufficiently relevant for the time periods covering the birth periods of the children in our CLIC dataset. Third, the JEM is based on an international occupational classification system (ISCO-68 and ISCO-88) allowing linkage with the occupational histories which were collected in CLIC.

Occupations in the ELF-MF JEM were coded according to the ISCO-88 unless exposure estimate was available for a more specific job in ISCO-68. Selected occupations with their respective ELF-MF exposure are shown in online [supplementary table 1](#SP1){ref-type="supplementary-material"}.
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We linked the ELF-MF JEM directly to datasets with occupations coded into ISCO-88 ([table 1](#T1){ref-type="table"}). In datasets with ISCO-68 codes, we translated ISCO-68 codes to ISCO-88 except for those codes that could be directly linked to the ELF-MF JEM. In the remaining datasets, job codes were translated to ISCO-88 by using correspondence tables ([table 1](#T1){ref-type="table"}). Some national job codes did not match to a single ISCO-88 code, which resulted in 'one-to-many' and 'many-to-one' translations and consequently multiple ELF-MF exposure assignments to the same persons. For such persons, we derived median and maximum ELF-MF exposure as a summary exposure estimate. The former was used in the main analyses and the latter in a sensitivity analyses.

Statistical analyses {#s2d}
--------------------

Two analytical approaches were used. First, we pooled the primary data from CLIC case--control studies and estimated summary ORs and 95% CIs using unconditional logistic regression models. We estimated ORs for parental ELF-MF exposure for ALL and its subtypes (B-lineage and T-lineage ALL) as well as for AML. Specific characteristics of the child and the parents were considered as potential confounders based on the associations between the available characteristics described in the literature. They were retained in the final models if they changed OR estimates for parental ELF-MF exposure by more than 5%. As a result, in the final models, we included the child's age and sex, highest level of education of either parent, case accrual time and primary study. Because birth weight, birth order and parental age did not change OR estimates by more than 5%, we did not retain them in the final models.

Second, we estimated ORs and 95% CIs for parental ELF-MF exposure in each individual study. In addition to adjustment variables used in the pooled analysis, we also controlled for study-specific adjustment variables (eg, hospital in France ADELE, region in Germany and Italy, maternal race in US California Childhood Leukemia Study (CCLS), and ethnicity in France ADELE, France ESCALE, New Zealand, US Children's Oncology Group (COG)-E15, US CCLS, and the UK Childhood Cancer Study (UKCCS). OR estimates from individual studies were subsequently summarised to give an overall OR estimate from a meta-analysis. We used a random effects model to account for heterogeneity between studies in terms of study design and time period of exposure assessment. Summary ORs and 95% CIs, *I^2^* statistics (a measure of variation across studies that is not due to chance)[@R29] and forest plots were produced. These analyses were conducted separately for ALL, AML and maternal and paternal exposure. In addition, we identified other studies reporting on parental ELF-MF exposure and childhood leukaemia risk by searching PubMed. We extracted the ORs from those studies and combined them using the meta-analysis approach with the ORs for overall leukaemia from the individual studies included in the current pooled analysis. Funnel plots were produced and Egger's test was performed to evaluate the effect of publication bias in this analysis.

In the pooled analysis, we categorised paternal occupational ELF-MF exposure at conception and maternal ELF-MF exposure during pregnancy to dichotomous exposure with categories of ≤0.2 microtesla (µT) and \>0.2 µT, and polytomous exposure with categories of ≤0.1 µT, \>0.1--≤0.2 µT, \>0.2--≤1 µT and \>1 µT. In meta-analysis, only dichotomous exposure was used.

Finally, we conducted sensitivity analyses to assess the robustness of the main findings from the pooled analyses as follows: (1) analyses stratified by child's year of birth were conducted to take into account possible change of ELF-MF exposure level over time; (2) analyses by using maximum ELF-MF exposure for parents with multiple exposure assignment due to 'one-to-many' and 'many-to-one' job code translations were conducted to assess whether the choice of summary exposure estimate (median or maximum ELF-MF) for such persons had an effect on the risk estimates; (3) analyses restricted to datasets with job histories coded into ISCO were carried out in order to reduce 'one-to-many' and 'many-to-one' job code translations; (4) analyses stratified by child's sex and age at diagnosis; and (5) finally, we used 0.4 µT as cut-off point for categorisation of dichotomous ELF-MF exposure.

Stata/IC V.14 was used for the meta-analyses, and R V.3.4.3 (R Core Team. 2017. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. <https://www.R-project.org/>) was used for the pooled analyses.

Results {#s3}
=======

The ALL analysis included 8420 cases (including 5845 B-lineage and 781 T-lineage) and 16 453 controls (including 13 815 B- lineage and T-lineage ALL controls) from 11 studies. The AML analysis included 926 AML cases and 12 246 controls from 10 studies ([table 2](#T2){ref-type="table"}).

###### 

Selected sociodemographic and prenatal characteristics of the study population of the pooled analysis

  Characteristics                         ALL (11 studies)   AML (10 studies)                                         
  --------------------------------------- ------------------ ------------------ -------- ------ ----- ------ -------- ------
  Child's characteristics                                                                                             
  *Sex*                                                                                                               
   Boy                                    4699               55.8               9097     55.3   483   52.2   6834     55.8
   Girl                                   3721               44.2               7356     44.7   443   47.8   5412     44.2
  Age at diagnosis/index date (years)\*                                                                               
   \<1                                    264                3.1                938      5.7    120   13.0   792      6.5
   1--4                                   4515               53.6               8024     48.8   302   32.6   5741     46.9
   5--9                                   2421               28.8               4689     28.5   228   24.6   3469     28.3
   10--14                                 1220               14.5               2802     17.0   274   29.6   2235     18.3
   Missing                                0                  0                  0        0      2     0.2    9        0.1
  Year of birth                                                                                                       
   ≤1980                                  446                5.5                879      5.3    59    6.4    524      4.3
   1981--1990                             3770               44.8               7030     42.7   329   35.5   4748     38.8
   1991--2000                             3258               38.7               6572     39.9   401   43.3   5553     45.3
   \>2000                                 946                11.2               1972     12.0   137   14.8   1421     11.6
  Case accrual time period†                                                                                           
   1988--1992                             2934               34.8               4856     29.5   159   17.2   2465     20.1
   1993--1997                             2181               25.9               5199     31.6   345   37.3   4660     38.1
   1998--2002                             1611               19.1               2910     17.7   180   19.4   2422     19.8
   2003--2007                             1291               15.3               2754     16.7   185   20.0   2292     18.7
   2008--2013                             403                4.8                734      4.5    57    6.2    407      3.3
  Parental characteristics                                                                                            
  Highest level of education‡                                                                                         
   Did not finish secondary education     1352               16.1               2455     14.9   189   20.4   2394     19.5
   Completed secondary education          3701               44.0               6914     42.0   363   39.2   4681     38.2
   Tertiary education                     3186               37.8               6528     39.7   346   37.4   4968     40.6
   Missing                                181                2.1                556      3.4    28    3.0    203      1.7
  Maternal job history available                                                                                      
   Yes                                    7864               93.4               15 884   96.5   902   97.4   12 005   98.0
   No                                     556                6.6                569      3.5    24    2.6    241      2.0
  Paternal job history available                                                                                      
   Yes                                    7842               93.1               15 301   93.0   855   92.3   11 281   92.1
   No                                     578                6.9                1152     7.0    71    7.7    965      7.9
  Histological subtype                                                                                                
   ALL B-lineage                          5845                                  13 815                                
   ALL T-lineage                          781                                   13 815                                
  Total                                   8420                                  16 453          926          12 246   

\*Child's age at the index date: for cases, the date of diagnosis, and for controls, either the date of recruitment or the date of questionnaire return.

†Date of interview or questionnaire return for the control.

‡Based on the highest attained education level by the parents (either mother or father).

ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia.

Because of missing job histories, 578 (6.9%) ALL cases and 1152 (7.0%) controls, and 71 (7.7%) AML cases and 965 (7.9%) controls were excluded from the analysis of paternal ELF-MF exposure ([table 2](#T2){ref-type="table"}). For the same reason, we excluded 556 (6.6%) ALL cases and 569 (3.5%) controls, and 24 (2.6%) AML cases and 241 (2.0%) controls from the analysis of maternal ELF-MF exposure ([table 2](#T2){ref-type="table"}).

As expected, ALL was most common in children aged 1--4 years, while AML was more evenly distributed in children aged 2 years or more. Slightly over 50% of cases with ALL or AML were boys ([table 2](#T2){ref-type="table"}).

Minimum estimated exposure for both parents was 0.02 µT, and the maximum estimated exposure for fathers was 17.88 µT (railway engine driver), and for mothers, it was 5.48 µT (locomotive engine driver). The most frequent occupations in this pooled case--control dataset are shown in online [supplementary table 1](#SP1){ref-type="supplementary-material"}.

Pooled analysis {#s3a}
---------------

The OR for ALL related to paternal ELF-MF exposure (\>0.2 µT vs ≤0.2 µT) was 1.04 (95% CI 0.95 to 1.13) and for maternal exposure it was 1.00 (95% CI 0.89 to 1.12). Similarly, no association was observed when using more categories of exposure, in particular, not in the highest exposure category \>1 µT for paternal exposure ([table 3](#T3){ref-type="table"}).

###### 

Estimated risk of acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML) in the offspring following parental occupational exposure to extremely low-frequency magnetic fields (ELF-MF) in a pooled analysis of Childhood Leukaemia International Consortium (CLIC) studies

  ELF-MF exposure, µT                           ALL           ALL T-lineage   ALL B-lineage   AML                                                                                        
  --------------------------------------------- ------------- --------------- --------------- ------------ ------ -------------- ------------- ------ -------------- ------------ ------ --------------
  Paternal ELF-MF exposure at conception†                                                                                                                                                
   ≤0.2                                         6862/13 379   1.00                            632/10 946   1.00                  4635/10 946   1.00                  723/9572     1.00   
   \>0.2                                        980/1922      1.04            0.95 to 1.13    90/1717      0.89   0.70 to 1.12   776/1717      1.09   0.99 to 1.19   132/1709     1.06   0.87 to 1.29
   ≤0.1                                         2403/4990     1.00                            185/3416     1.00                  1497/3416     1.00                  313/3290     1.00   
   \>0.1--≤0.2                                  4459/8389     0.96            0.90 to 1.02    447/7530     1.04   0.87 to 1.24   3138/7530     0.93   0.86 to 1.00   410/6282     0.81   0.69 to 0.96
   \>0.2--≤1                                    936/1792      1.03            0.93 to 1.13    88/1601      0.94   0.72 to 1.23   738/1601      1.04   0.93 to 1.16   122/1593     0.92   0.73 to 1.15
   \>1                                          44/130        0.79            0.55 to 1.11    2/116        0.36   0.06 to 1.17   38/116        0.91   0.62 to 1.31   10/116       1.21   0.58 to 2.24
  Maternal ELF-MF exposure during pregnancy†‡                                                                                                                                            
   ≤0.2                                         7393/14 966   1.00                            689/12 490   1.00                  5128/12 490   1.00                  857/11 296   1.00   
   \>0.2                                        471/918       1.00            0.89 to 1.12    43/756       0.95   0.68 to 1.30   329/756       0.98   0.85 to 1.12   45/709       0.85   0.61 to 1.16
   ≤0.1                                         4313/9143     1.00                            382/7239     1.00                  2939/7239     1.00                  564/6970     1.00   
   \>0.1--≤0.2                                  3080/5823     0.98            0.92 to 1.04    307/5251     1.07   0.90 to 1.26   2189/5251     0.95   0.89 to 1.02   293/4326     0.89   0.76 to 1.04
   \>0.2                                        471/918       0.99            0.88 to 1.11    43/756       0.98   0.70 to 1.35   329/756       0.96   0.83 to 1.10   45/709       0.82   0.58 to 1.11

\*Adjusted for child's age and sex, highest level education of either parent, case accrual time, study.

†Median of ELF-MF was used for persons with multiple exposure assignment due to 'one-to-many' job title conversion.

‡Due to small number of exposed cases in the category of \>1 µT, it was collapsed with category of \>0.2-≤1 µT.

µT, microtesla.

Similarly, no evidence of an effect was found for AML. The OR for paternal exposure (\>0.2 µT vs ≤0.2 µT) was 1.06 (95% CI 0.87 to 1.29) and for maternal exposure 0.85 (95% CI 0.61 to 1.16) ([table 3](#T3){ref-type="table"}).

The OR for all leukaemia related to paternal ELF-MF exposure (\>0.2 µT vs ≤0.2 µT) was 1.04 (95% CI 0.96 to 1.13) and for maternal exposure 0.99 (95% CI 0.89 to 1.11) (table not shown).

These results did not change when maximum ELF-MF exposure was used instead of median ELF-MF exposure (data not shown). No large differences in risk estimates were observed for children born before or after 1990 (online [supplementary table 2](#SP1){ref-type="supplementary-material"}). Main results did not change also in other sensitivity analyses (online [supplementary tables 3--6](#SP1){ref-type="supplementary-material"}).

Meta-analysis {#s3b}
-------------

Summary OR in the meta-analysis of paternal ELF-MF exposure and ALL was 1.05 (95% CI 0.96 to 1.14) ([figure 1](#F1){ref-type="fig"}) and in the analysis of maternal ELF-MF exposure and ALL was 0.99 (95% CI 0.88 to 1.12) ([figure 1](#F1){ref-type="fig"}).

![Parental occupational ELF-MF exposure and acute lymphoblastic leukaemia (ALL) in the offspring. CCLS, California Childhood Leukemia Study; COG, Children's Oncology Group; ELF-MF, extremely low-frequency magnetic field; NARECHEM, Nationwide Registry for Childhood Haematological Malignancies; SETIL, Studio sulla Eziologia dei Tumori Infantili Linfoemopoietici.](oemed-2019-105706f01){#F1}

OR for paternal ELF-MF exposure and AML was 1.07 (95% CI 0.87 to 1.32) ([figure 2](#F2){ref-type="fig"}), and for maternal ELF-MF exposure and AML it was 0.93 (95% CI 0.67 to 1.30) ([figure 2](#F2){ref-type="fig"}). France ADELE was not included in the maternal exposure analysis because there were no mothers with exposure level \>0.2 µT in this dataset ([figure 2](#F2){ref-type="fig"}).

![Parental occupational ELF-MF exposure and acute myeloid leukaemia (AML) in the offspring. CCLS,  California Childhood Leukemia Study; COG,  Children's Oncology Group;  ELF-MF,  extremely low-frequency magnetic field; NARECHEM, Nationwide Registry for Childhood Haematological Malignancies; SETIL, Studio sulla Eziologia dei Tumori Infantili Linfoemopoietici.](oemed-2019-105706f02){#F2}

The meta-analysis of parental ELF-MF exposure and total leukaemia included 15 studies (11 CLIC and 4 additional studies). An increased overall risk of leukaemia with borderline significance was observed for paternal ELF-MF exposure at conception (OR=1.11, 95% CI 1.00 to 1.22) (online [supplementary figure 1](#SP1){ref-type="supplementary-material"}) but not for maternal ELF-MF exposure during pregnancy (OR=1.04, 95% CI 0.92 to 1.17) (online [supplementary figure 3](#SP1){ref-type="supplementary-material"}). Funnel plot and Egger's test (p=0.03) suggested a presence of publication bias in the analysis of parental exposure and leukaemia (online [supplementary figures 3 and 4](#SP1){ref-type="supplementary-material"}).

Discussion {#s4}
==========

In this large-scale international pooling effort, we found no clear evidence for an association between parental occupational ELF-MF exposure and ALL or AML in their offspring. This was consistent for the pooling approach and the meta-analytical approach of combining studies and confirmed in various sensitivity analyses.

A small increased risk of leukaemia in relation to paternal ELF-MF exposure in the meta-analysis of 11 CLIC plus four other published studies must have been due to the added studies especially from the UK and Russia, because this association was not observed for the CLIC pooled studies. With the addition of those studies, exposure assessment was no longer harmonised. Moreover, funnel plot and Egger's test suggested the presence of publication bias. It appears to confirm what was previously suggested by Hug *et al*,[@R22] namely that publication bias is a concern, confirming the need of studying this exposure in an unbiased dataset with regard to the original hypothesis, as discussed in more detail below.

Two of the studies included in our analyses, the German Childhood Cancer Registry and the UK Childhood Cancer  Study (UKCCS) had already published their findings,[@R21] and their individual findings were consistent with the current analyses. Two other studies that are part of the CLIC consortium, the Quebec study[@R20] and Aus-ALL from Australia,[@R23] were not included in these analyses since both used expert assessment rather than quantitative JEM. While the earliest of these by Infante-Rivard and Deadman[@R20] in Quebec observed an increased risk of childhood leukaemia (OR=2.5, 95% CI 1.2 to 5.0) for maternal ELF-MF exposure during pregnancy for exposure level ≥0.4 µT, the findings of the later Australian study were consistent with ours, despite the different method of exposure assessment.

Among studies that are not part of CLIC, our findings were inconsistent with the results from Pearce *et al* [@R19] and Smulevich *et al*.[@R18] Pearce *et al* [@R19] included cases diagnosed between 1968 and 2000 in the UK, which has some overlap with the UKCCS among cases diagnosed between 1991 and 1996. Pearce *et al* [@R19] found an increased leukaemia risk in relation to paternal occupational electromagnetic field exposure (OR=1.31, 95% CI 1.02 to 1.69),[@R19] and Smulevich *et al* [@R18] reported increased risk in relation to both parents' exposure (OR=4.6, 95% CI 1.8 to 11.9 for fathers' exposure, and OR=5.2, 95% CI 1.6 to 16.8 for mothers' exposure).[@R18] However, these results should be interpreted with caution. For example, in Pearce *et al* [@R19] and Smulevich *et al*,[@R18] only those occupations categorised as probably exposed and probably unexposed were considered. Moreover, results from Smulevich *et al* [@R18] were based on a small number of events: 14 cases in the analysis of paternal exposure and 10 cases in the analysis of maternal exposure. As previously stated, a meta-analysis of studies published at that time showed strong evidence of publication bias.[@R22] This is in line with our finding of no association based on the sample of CLIC studies alone but an increased OR with the addition of the remaining studies with positive associations from the literature.

The strengths of this study include its large size. It is the largest study to assess parental ELF-MF exposure and childhood leukaemia to date. Childhood leukaemia is relatively rare, and high ELF-MF exposure is also rare in the general population, so a large study is required to detect potential risks should they exist. Completeness of parental job history data was another advantage of our study. The vast majority of women included in CLIC datasets had the same job in pregnancy as in the period prior to conception.[@R26] Among the studies that had information about more than one job during pregnancy, we used the information if any of the jobs was associated with exposure. In total, only 6.8% of paternal and 4.3% of data on maternal job histories were missing, while detailed job histories with start and end dates of each job were available in most included studies. We quantified parental occupational ELF-MF exposures by linking parental jobs at the relevant time period to an ELF-MF JEM. Using an ELF-MF JEM for exposure estimation is a more rigorous method compared with merely grouping persons into exposed versus unexposed categories and allows harmonisation across studies. In addition, the ELF-MF JEM used in our study is quantitative and based on real ELF-MF workplace measurement series in the occupational setting.[@R27] As described in the Methods, the ELF-MF JEM was developed independently from our study; however, it was for an international collaboration capturing similar countries and the same time period as our pooled dataset, therefore it was well applicable for our setting.

The major limitation of this study was potential exposure misclassification, which can arise in any study with retrospective exposure assessment. Exposure misclassification could occur because the ELF-MF JEM, like most JEMs, assigns the mean exposure level to all persons in the same occupation, while exposure heterogeneity within the occupation may be substantial. It does not specify jobs by industrial groups, and exposure intensity might vary in the same occupation by industrial group. Finally, when national codes were translated to ISCO, this resulted in 'one-to-many' and 'many-to-one' job code translations, which introduced further exposure uncertainty for some persons. We assessed the effect of the latter by restricting analyses to studies using the ISCO classification, and the main results did not change, suggesting that 'one-to-many' and 'many-to-one' job code translations had no effect on the risk estimates. Exposure misclassification was likely to be non-differential in our study because the JEM was applied in the same way to all parents and independently of case--control status of the child. Bias from non-differential exposure misclassification is generally towards the null for dichotomous exposures.[@R30] For polytomous exposures, non-differential misclassification can bias ORs away from the null only for intermediate exposure categories, but ORs for the highest category will be towards the null.[@R31] Therefore, ORs for dichotomous ELF-MF exposures and for high categories of polytomous exposures would be underestimated if non-differential exposure misclassification was present in this study.

Selection bias may also be a concern in this study. In most of the included studies, higher response rates of case parents compared with control parents, and mothers compared with fathers were noted.[@R26] Selection bias could occur also in analyses of maternal exposure and ALL, because 6.6% case mothers were excluded from the analysis compared with only 3.5% control mothers due to missing occupational data. Recall bias is, however, unlikely to be an issue in the present study because job title rather than exposure information was collected from study participants. It has been shown that the validity and reliability of self-reported job histories obtained using an interview-administered questionnaire are generally good and not subject to recall bias.[@R32]

In conclusion, using a large international pool of case--control studies and a detailed quantitative JEM, we did not find any evidence for an association between fathers' occupational ELF-MF exposures around the time of conception or mothers' occupational ELF-MF exposures during pregnancy and leukaemia in their offspring. Considering our findings and those of previous smaller less consistent studies together suggests that parental ELF-MF exposure plays no relevant role in the aetiology of childhood leukaemia.

The authors would like to thank Veronique Luzon (International Agency for Research on Cancer (IARC)) for her skilful data management for the CLIC Data Coordination Center. The authors would also like to thank Sini Erme, MD (Tampere University Hospital) for contributions to the Finnish study. For the Germany GCCR study, we would like to thank Drs Peter Kaatsch, Rolf Meinert, Uwe Kaletsch and Jörg Michaelis for their work in the original study. For the Greece NARECHEM study, we would like to thank Nick Dessypris. For New Zealand, GP Herbison, DCG Skegg and JM Elwood are thanked for their contributions to the original study. For Italy, SETIL, Alessandra Benvenuti and Patrizia Legittimo (Occupational and Environmental Epidemiology Unit, ISPRO Cancer Prevention and Research Institute, Florence, Italy), Marco Gilardetti and Assunta Rasulo (Cancer Epidemiology Unit, CPO Piedmont and University of Turin, Torino, Italy) and Alessandra Ranucci (Cancer Epidemiology Unit, Department of Translational Medicine, CPO Piedmont and University of Eastern Piedmont, Novara, Italy). The SETIL (Italian Multicentric Epidemiological Study on Risk Factors of Childhood Leukaemia, Non-Hodgkin Lymphoma and Neuroblastoma) Working Group was listed in: Magnani C, Mattioli S, Miligi L *et al*. SETIL: Italian multicentric epidemiological case-control study on risk factors for childhood leukaemia, non hodgkin lymphoma and neuroblastoma: study population and prevalence of risk factors in Italy. *Ital J Pediatr*. 2014;40:103. doi: 10.1186/s13052-014-0103-5. The authors would also like to thank research investigator from French studies ADELE and ESCALE, Jacqueline Clavel, and principal investigators from The Société Française de lutte contre les Cancers de l'Enfant et de l'Adolescent (SFCE): André Baruchel (Hôpital Saint-Louis/Hôpital Robert Debré, Paris), Claire Berger (Centre Hospitalier Universitaire, Saint-Etienne), Christophe Bergeron (Centre Léon Bérard, Lyon), Jean-Louis Bernard (Hôpital La Timone, Marseille), Yves Bertrand (Hôpital Debrousse, Lyon), Pierre Bordigoni (Centre Hospitalier Universitaire, Nancy), Patrick Boutard (Centre Hospitalier Régional Universitaire, Caen), Gérard Couillault (Hôpital d'Enfants, Dijon), Christophe Piguet (Centre Hospitalier Régional Universitaire, Limoges), Anne-Sophie Defachelles (Centre Oscar Lambret, Lille), François Demeocq (Hôpital Hôtel-Dieu, Clermont-Ferrand), Alain Fischer (Hôpital des Enfants Malades, Paris), Virginie Gandemer (Centre Hospitalier Universitaire -- Hôpital Sud, Rennes), Dominique Valteau-Couanet (Institut Gustave Roussy, Villejuif), Jean-Pierre Lamagnere (Centre Gatien de Clocheville, Tours), Françoise Lapierre (Centre Hospitalier Universitaire Jean Bernard, Poitiers), Guy Leverger (Hôpital Armand-Trousseau, Paris), Patrick Lutz (Hôpital de Hautepierre, Strasbourg), Geneviève Margueritte (Hôpital Arnaud de Villeneuve, Montpellier), Françoise Mechinaud (Hôpital Mère et Enfants, Nantes), Gérard Michel (Hôpital La Timone, Marseille), Frédéric Millot (Centre Hospitalier Universitaire Jean Bernard, Poitiers), Martine Münzer (American Memorial Hospital, Reims), Brigitte Nelken (Hôpital Jeanne de Flandre, Lille), Hélène Pacquement (Institut Curie, Paris), Brigitte Pautard (Centre Hospitalier Universitaire, Amiens), Stéphane Ducassou (Hôpital Pellegrin Tripode, Bordeaux), Alain Pierre-Kahn (Hôpital Enfants Malades, Paris), Emmanuel Plouvier (Centre Hospitalier Régional, Besançon), Xavier Rialland (Centre Hospitalier Universitaire, Angers), Alain Robert (Hôpital des Enfants, Toulouse), Hervé Rubie (Hôpital des Enfants, Toulouse), Stéphanie Haouy (Hôpital Arnaud de Villeneuve, Montpellier), Christine Soler (Fondation Lenval, Nice) and Jean-Pierre Vannier (Hôpital Charles Nicolle, Rouen).

**Contributors:** MT, JS, AO, FE and HB designed the study. MT conducted data analyses and wrote the manuscript. The results were interpreted and manuscript was revised by all authors.

**Funding:** The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

**Competing interests:** None declared.

**Ethics approval:** Individual studies were approved by their respective ethical committees (COG-E15 study: Minnesota Human Subjects Research Protection Program, study approval number 1403E49261; ADELE study: CNIL (339392) -- RBM (CCPPRB 1995/9443); ESCALE study: CNIL (902162) -- RBM (DGS 2003/0259); CCLS study: Committee for Protection of Human Subjects (CPHS), University of California, Berkeley, CPHS Protocol Number 2010-10-2438; NZCCS study: Ethical Committees of Waikato Area Health Board RDL:JD, Auckland Area Health Board 90/20 Committee B, Otago Area Health Board 216 00001207, Southland Area Health Board 13-3-1-7, West Coast Area Health Board, Nelson Marlborough Area Health Board, Hawkes Bay Area Health Board 1991/5, Manawatu-Manganui Area Health Board 2/91, Taranaki Area Health Board, Tairawhiti Area Health Board, Bay of Plenty Area Health Board, Canterbury Area Health Board WJP/AQ, Wellington Area Health Board Te Waiora a Tara 90/82; GCCR study: ethical and data protection approval granted by University of Mainz, 1990 (IMSD-1990); SETIL study: Ethical Review Board for the Piedmont Region, authorisation n. 2886, on 15/2/1999, letter n. 1852/28.3 on 17/2/1999; UKCCS study: Yorkshire and the Humber -- Leeds West Research Ethics Committee 18/YHO/0135; Integrated Research Application System 203822; Confidential Advisory Group (CAG) 18/CAG/0066; Greece NARECHEM 1993-1994 study: no ethics committee had been established at that time; the dataset was used in doctoral thesis supervised by the principal investigator E Petridou; Greece NARECHEM 1996-2011 study: Ethics Committee of the National and Kapodistrian University of Athens, letter on 20 March 2000, authorization n. 5097 on 17 February 2012 and authorisation n. 1516003877 on 9 October 2015 as the study expanded; written informed consents obtained from family members who provided data in the presence of the child). In interview-based studies, written informed consent was obtained from family members who provided data.

**Provenance and peer review:** Not commissioned; externally peer reviewed.

**Correction notice:** This article has been corrected since it published Online First.

**Patient consent for publication:** Not required.
